100 Biotech Investors Cram into L'Auberge; IR PR Strategies, LLC Announces Name Change
SAN DIEGO, Sept. 28 /PRNewswire/ -- One hundred biotech investors crammed
into the L'Auberge Resort & Spa today to see six biotech companies discuss the
biotechnology industry and its investment potential. IR PR Strategies, LLC,
which unveiled its name change to Susan E. Atkins & Associates, hosted the
event.
The event included San Diego based Diversa Corporation (Nasdaq: DVSA),
ISIS Pharmaceuticals (Nasdaq: ISIP) and Epimmune Inc. (Nasdaq: EPMN). Also
present were South San Francisco based, Cellegy Pharmaceuticals
(Nasdaq: CLGY), SONUS Pharmaceuticals (Nasdaq: SNUS) from Bothell, Washington
and StemCells Inc. (Nasdaq: STEM) from Sunnyvale, CA.
"Biotechnology investing is not for sissies," said Susan E. Atkins,
President & CEO. "These companies are changing the way medicine will be
practiced in the future, and my goal is that everyone attending will discover
a new investment candidate today."
After the conference IR PR Strategies hosted a Client Appreciation Party
in which it unveiled its new name and logo. The Company recently surpassed
the million-dollar mark in revenues and Atkins felt it was time for a name
change.
"The reason for the name change is simple. This is a professional firm,
and people want to know who stands behind it. I do," Atkins said.
Susan E. Atkins & Associates specializes in investor relations and public
relations for biotech companies. The firm's clients are some of the leading
biotech companies in the industry, including, Aclara Biosciences, Cellegy
Pharmaceuticals, Ciblex Corporation, Corvas International, Discovery
Therapeutics, Diversa Corporation, Epimmune Inc., Genteric Incorporated,
Immune Response Corporation, LigoCyte Pharmaceuticals, Inc., Natural
Alternatives International, Pharmos Corporation, SONUS Pharmaceuticals,
StemCells, Inc., Triad Therapeutics, Tanabe Research Laboratories USA, Inc.
CONTACT: Susan E. Atkins of Susan E. Atkins & Associates, 858-860-0266.
SOURCE Susan E. Atkins & Associates
Web Site: irpr.com |
